Click chemistry advances precision oncology by merging imaging and therapyly
Conventional cancer treatments like chemotherapy often struggle with poor targeting, leading to severe systemic toxicity and drug resistance.
another news portal
Conventional cancer treatments like chemotherapy often struggle with poor targeting, leading to severe systemic toxicity and drug resistance.
Communication begins long before children learn to speak. Researchers at National Yang Ming Chiao Tung University (NYCU) in Taiwan have now uncovered how early brain
Argentine investigators searching for the source of a deadly hantavirus outbreak on a cruise last month were trapping rodents in the forests surrounding the southernmost
Pre-eclampsia causes more than 70,000 maternal deaths every year worldwide
It’s spring cleaning season, and for some people that means drudgery or anxiety
Another attempt to demonstrate that the fiction of acupuncture is based in reality. This time it is the interstitium. Nope. The post Lipstick on Fengxi
Hundreds of cases are suspected in central Africa but experts fear the actual number may be much higher.
A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine study that uncovered how tumors
Giving whole blood or the component parts of blood are equally effective options for paramedics and emergency medical technicians to use in treating patients with
For the first time, scientists have directly measured how smoking changes the mechanical behavior of human lung tissue.
Proteins are critical to life – and to industry. There are countless proteins that could be engineered to treat and even cure serious diseases and
A University of Bath-led project has secured £500,000 to develop a first-of-its-kind ‘organ-on-chip’ device that replicates connections between the brain, gut and pancreas.
The Congolese health ministry is reporting that there have been at least 131 deaths and over 500 suspected cases in the ongoing Ebola outbreak in
An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of